Real-World Feasibility Assessment of Short-Course Preoperative Endocrine Therapy Using the Ki67 Biomarker in an Australian Cohort of Patients With Estrogen Receptor–Positive Early Breast Cancer

Clinical Breast Cancer · Published 2026-07-30 · DOI 10.1016/j.clbc.2026.07.011

Authors (5)

Oliver Nilsen, David S. Williams, Chang-Hao S. Tsao, Shane White, Belinda Yeo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Nilsen, O., Williams, D., Tsao, C., et al. (2026). Real-World Feasibility Assessment of Short-Course Preoperative Endocrine Therapy Using the Ki67 Biomarker in an Australian Cohort of Patients With Estrogen Receptor–Positive Early Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.07.011

Related articles